# Obesity & GLP-1 Drug Trial Readouts (Lilly, Novo, Amgen)

**Use case:** 

Upcoming clinical-trial readouts and phase changes for obesity/GLP-1 drugs from Eli Lilly, Novo Nordisk and Amgen, impact-scored.

## Input

```json
{
  "sponsors": [
    "Eli Lilly",
    "Novo Nordisk",
    "Amgen"
  ],
  "maxStudies": 50,
  "minImpact": 0
}
```

## Output

```json
{
  "type": {
    "label": "Type"
  },
  "sponsor_query": {
    "label": "Company"
  },
  "trials_found": {
    "label": "# Trials"
  },
  "high_impact_count": {
    "label": "# High-impact"
  },
  "catalysts": {
    "label": "Catalysts"
  }
}
```

## About this Actor

This example demonstrates how to use [Biotech Catalyst Monitor: Clinical Trial Readouts & Signals](https://apify.com/datasignalslab/biotech-catalyst-monitor) with a specific input configuration. Visit the [Actor detail page](https://apify.com/datasignalslab/biotech-catalyst-monitor) to learn more, explore other use cases, and run it yourself.